MIR3181

Across TCGA pan-cancer cohorts, MIR3181 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated MIR3181 data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher MIR3181 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR3181 expression acts as an unfavorable survival marker, although some lineages such as KIRC and GBM show a favorable association.

THCA, CHOL, and MESO are the cancer types where MIR3181 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	OS	Tertile	All	0.588	0.963	.001	93	view →
CHOL	OS	Tertile	All	0.057	0.723	<.001	90	view →
MESO	OS	Tertile	III,IV	0.036	0.563	<.001	54	view →
TGCT	OS	Tertile	II,III,IV	0.501	0.996	<.001	54	view →
ACC	OS	Tertile	All	0.140	0.705	<.001	39	view →
LUSC	OS	Tertile	IV	0.001	0.673	.014	36	view →
LIHC	DFS	Tertile	II,III,IV	0.136	0.468	.039	18	view →
PCPG	OS	Tertile	All	0.904	0.985	.019	15	view →
KIRC	DFS	Tertile	All	0.834	0.580	.028	6	view →
GBM	OS	Tertile	All	0.393	0.244	.047	3	view →
OV	DFS	Median	All	0.422	0.357	.045	2	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

MIR3181–THCA (OS)

Open the THCA breakdown →